IMMUNOLOCATION OF TNF-ALPHA CACHECTIN IN HUMAN-MELANOMA CELLS - STUDIES ON CO-CULTIVATED MALIGNANT-MELANOMA

被引:17
作者
LUGASSY, C
ESCANDE, JP
机构
[1] Laboratoire d'Oncologie, Hôpital Tarnier-Cochin, Paris
关键词
D O I
10.1111/1523-1747.ep12462141
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We have investigated the ability of metastatic cells to produce the macrophage cytokine, TNF-alpha/cachectin, as these cells have macrophage-like properties such as infiltration and migration. We looked for TNF-alpha/cachectin in three tumor cell lines derived from human malignant melanomas and six co-cultivated malignant melanomas derived, in vitro, from these cell lines plus angioma fibroblasts. Immunohistochemistry with an anti-TNF-alpha/cachectin monoclonal antibody showed that TNF-alpha/cachectin was produced by two of the three parent melanoma cell lines. All the tumor cells in both the co-cultivated malignant melanomas and their in vitro tumorous nodules produced TNF-alpha/cachectin, even those derived from the melanoma cell line, which originally did not. The results clearly show that TNF-alpha/cachectin can be produced by non-hematopoietic tumor cells. A co-cultivated tumor model prepared from other types of human tumor cell lines promises to provide a useful tool for exploring the relationship between TNF-alpha/cachectin and oncogenesis.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 33 条
[1]  
ADERKA D, 1985, LANCET, V2, P1190
[2]  
BAKOUCHE O, 1988, J IMMUNOL, V140, P1142
[3]  
BALKWILL F, 1987, LANCET, V2, P1229
[4]   REGULATION OF TUMOR NECROSIS FACTOR GENE-EXPRESSION IN COLORECTAL ADENOCARCINOMA - INVIVO ANALYSIS BY INSITU HYBRIDIZATION [J].
BEISSERT, S ;
BERGHOLZ, M ;
WAASE, I ;
LEPSIEN, G ;
SCHAUER, A ;
PFIZENMAIER, K ;
KRONKE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :5064-5068
[5]   PRODUCTION OF A TISSUE-LIKE STRUCTURE BY CONTRACTION OF COLLAGEN LATTICES BY HUMAN-FIBROBLASTS OF DIFFERENT PROLIFERATIVE POTENTIAL INVITRO [J].
BELL, E ;
IVARSSON, B ;
MERRILL, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (03) :1274-1278
[6]  
CARIANI E, 1988, CANCER RES, V48, P6844
[7]  
CERAMI A, 1985, IMMUNOL LETT, V11, P173, DOI 10.1016/0165-2478(85)90165-8
[8]  
CHENSUE SW, 1988, AM J PATHOL, V133, P564
[9]  
DUNCOMBE AS, 1988, NEW ENGL J MED, V319, P1227
[10]  
ESCANDE JP, 1983, ANN MED INTERNE, V134, P77